|
|||
|
||||||
|
SPA News Update December 20, 2006 NEWS/FUNDING OPPORTUNITIES AROUND SPA Biomedical Research Support Bridging Fund The next deadline to submit the Biomedical
Research Support Bridging Fund application is: FRIDAY, DECEMBER
29, 2006 Click
here for application requirements. NIH ELECTRONIC SUBMISSION ITEMS OF INTEREST NIH Training: Preparing For NIH Electronic Grant Application NIH held a presentation on December 5, 2006, to prepare the applicant community for the upcoming transition of R01’s to electronic submission. The presentation included an overview of the electronic submission process, a walk through the SF424 (R&R) grant application form, and “Lessons Learned” presented by a panel of e-Submission experts. There was also a question-and-answer session with the panel at the close of the presentation. Click here to view the presentation. PureEdge Options for MAC Users Grants.gov has posted on their Web site an update on IBM’s progress towards providing a PureEdge viewer compatible with Macs. They have included a link to an early-release of an IBM Workplace Forms (PureEdge) viewer for Macs on their Download Software page and have identified some of the limitations to this version of the viewer (e.g., compatible only with PowerPC based machines – G4 and G5). While this is not the solution NIH and many of you had been hoping for, it may be a viable option for some of you. NIH Will Not Penalize You For Grants.Gov Or Era Commons Systems Issues The forms are different. The submission method has changed. Some things, however, remain the same—it is still about the science and getting the best applications in the door and ready for review. So, if you follow the application guide and opportunity instructions and do everything you can to successfully submit your application on time, but then cannot complete the submission because of a Grants.gov or eRA Commons system failure do not despair. Help is available and NIH will ensure that you are not penalized for a Grants.gov or eRA Commons system problem. To provide a fair and competitive process, all applicants must follow the same rules for application submission. The most common reason for unsuccessful application submissions is because the applicant did not follow the application guide and funding opportunity instructions. Unsolicited Applications: Use "Parent" Announcements NIH’s interest in pioneering new areas of investigation is stronger than ever. The implementation of “Parent” Funding Opportunity Announcements (FOAs) is a strategic part of this interest. To apply for a grant from NIH, all applications now must be submitted in response to an FOA. Parent FOAs are designed to provide a solicitation mechanism for unsolicited, investigator-initiated applications. Responding to a Parent FOA ensures that the correct application package is used by applicants, and enables NIH to receive the application through Grants.gov. NATIONAL INSTITUTES OF HEALTH Limits on Resubmission
of an Application: Clarification of NIH Policy The purpose of this notice is to clarify the National Institutes of Health (NIH) policy on the number of resubmissions (known previously as revisions or amendments) allowed for a NIH grant application. NIH will not consider a third resubmission (A3) or higher to any application for extramural support. However, there is no time limit for the submission of the first and second resubmissions (A1 and A2). NIH Fiscal Policy
for Grant Awards – FY 2007 New Limits on
Appendix Materials for Applications Beginning with Receipt Dates
On or After January 3, 2007 The purpose of this Notice is to announce a change in policy limiting Appendix materials that may be submitted with grant applications to NIH/AHRQ/NIOSH. The goal of changing the guidelines for grant application Appendix materials is to encourage applications to be as concise as possible while containing the information needed for expert scientific review. These changes take advantage of electronic access to many publications and should make application preparation and handling easier for both applicants and reviewers. It is important to note that the Appendix may not be used to circumvent the page limitations of the Research Plan. Confirm R01 Electronic
Application Submission Plans for February 5 Receipt Date The purpose of this Notice is to inform the grantee community that NIH/AHRQ/NIOSH will move forward with the R01 transition to electronic submission of grant applications using the SF424 (R&R) forms for the February 5, 2007 receipt date and beyond. Note that new standard receipt dates take effect in January 2007 (see NOT-OD-07-001); therefore, the R01 transition date has been moved from February 1 to February 5 to match the new standard receipt date. The electronic submission timeline has been updated to reflect the new receipt dates. Effective for R01 receipt dates on or after February 5, 2007, ALL applications in response to announcements for the R01 grant program must be submitted electronically (i.e., paper applications will not be accepted). Applications that were first submitted in paper and are being resubmitted as amended applications must now use electronic submission via Grants.gov using the SF424 (R&R) forms. Electronic grant applications must be submitted in response to a Funding Opportunity Announcement (FOA) posted on Grants.gov and the NIH Guide for Grants and Contracts. The Grants.gov model requires that all applications be submitted in response to a specific Funding Opportunity Announcement. Only the specific application package posted with the FOA can be used for submission. NIH still welcomes unsolicited, investigator-initiated applications. General-use “Parent Announcements” have been created with application packages appropriate for submission of unsolicited research proposals. The R01 parent announcement can be found at: PA-07-070. Applicants are advised that new options are now available for Mac users. Click here for additional information. NIH Policy on
Late Submission of Grant Applications – Clarification for
Multiple PI and New Applications NIH has recently announced the plans for extending the multiple PI option to most research grant applications as the grant mechanisms transition to electronic submission (Notice OD-07-017). One of the explanations for late submission that may lead to acceptance of an application is service by the Principal Investigator on an NIH extramural review group during the time frame that would reasonably be expected to be used to prepare the application. For multiple PI applications, this will apply when any one (or more) of the Project Directors/Principal Investigators (PD/PIs) is involved with service on an NIH extramural peer review group. Note that this applies only to NIH extramural review activities, not to those of other Federal agencies or private organizations. It also does not apply to other participants in the application who do not have the PD/PI role. Revision of the
Ruth L. Kirschstein National Research Service Awards for Individual
Predoctoral Fellowships (F31) to Promote Diversity in Health-Related
Research Effective January 1, 2007, all applications in response to this and subsequent FOAs will have the following tri-annual receipt dates: April 13, August 13, and December 13. The revised FOA amends the application submission requirements. Specifically, it adds a new bullet in the “Content and Form of Application Submission” section to require information that must be submitted by the applicant Institution in a letter certifying that the applicant is: (A) An individual from racial and ethnic groups that have been shown to be underrepresented in health-related sciences on a national basis; or (B) An individual with disabilities, who are defined as those with a physical or mental impairment that substantially limits one or more major life activities; or (C) An individual from disadvantaged backgrounds as defined in the FOA. For detailed information on the above categories, please refer to the “Eligible Individuals” section of the FOA. The revised FOA updates information on Tuition/Fees and Institutional Allowance, recently published in the NIH Guide: NOT-OD-06-093.
The Goldhirsh Foundation is pleased to announce the 2007 Grant Cycle of the Brain Tumor Research Awards Program. Investigators are required to submit Letters of Intent using the online grant submission process. Mailed applications for the Letter of Intent will not be reviewed. Please read the Application Guidelines and Terms of the Award carefully prior to beginning the online submission process. Your final version must be submitted online by Wednesday, 12:00 noon, January 10, 2007, EST. Click here for more information. THE NEW YORK ACADEMY OF MEDICINE Research Fellowships: Edwin
Beer Research Fellowship in Urology and Urology-Related Fields Application deadline: March 26, 2007
Charles
A. Elsberg Fellowship in Neurological Surgery Application deadline: February 20,
2007 Glorney-
Raisbeck Fellowship in Cardiovascular Diseases Application deadline: February 4, 2007
Mary
and David Hoar Fellowship in the Prevention and Treatment of Hip
Fracture Application Deadline: February 26,
2007 Ferdinand
C. Valentine Fellowship for Laboratory or Clinical Research in Urology Application deadline: March 5, 2007
Medical Student Grants: Glorney-
Raisbeck Medical Student Grants in Cardiovascular Research Application deadline: March 16, 2007 David
E. Rogers Fellowship Program Application deadline: March 16, 2007 Louis
L. Seaman Medical Student Research Grants in Microbiology Application deadline: March 16, 2007 Ferdinand
C. Valentine Student Research Grants in Urology Application deadline: March 16, 2007 SANDLER PROGRAM FOR ASTHMA RESEARCH The Sandler Program for Asthma Research seeks to develop important new pathways of investigation in basic research on the pathogenesis of asthma. Because the program seeks groundbreaking ideas,
outstanding investigators from outside the field of asthma are particularly
encouraged to apply. Preliminary results are not required. Investigators
with prior experience in asthma research are eligible to apply,
but they must demonstrate that the proposed work represents a departure
from their current and past research.
Pfizer, Inc. is proud to present its Medical & Academic Partnerships (MAP) grants – a reflection of Pfizer’s commitment to advancing research, innovation, and education in academic medicine, health literacy, health disparities, health policy, and public health. Medical & Academic Partnerships (MAP) grants are classified into four program types: Pfizer Fellowships, Pfizer Scholars Grants, Pfizer Visiting Professorships, and Additional Pfizer Programs. Pfizer Fellowships
For a complete list of Pfizer Fellowships, click here. Pfizer Scholars
Grants For a complete list of Pfizer Scholars Grants, click here. Pfizer Visiting
Professorships For a complete list of Pfizer Visiting
Professorships, click
here. |
||||||
